Your browser doesn't support javascript.
loading
Does endoscopic sphincterotomy contribute to the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis after endoscopic biliary stenting for malignant biliary obstruction? A multicenter prospective cohort study.
Nebiki, Hiroko; Fujita, Koichi; Yazumi, Shujiro; Takenaka, Mamoru; Maruo, Toru; Matsumoto, Kazuya; Asada, Masanori; Eguchi, Takaaki; Matsubara, Tokuhiro; Yasumura, Satoki; Matsumoto, Hisakazu; Tamura, Takashi; Marui, Saiko; Hasegawa, Kazunori; Mitoro, Akira; Masuda, Atsuhiro; Takada, Ryoji; Minami, Ryuki; Ogura, Takeshi; Hoki, Noriyuki; Funatsu, Eiji; Kurita, Akira; Onoyama, Takumi; Tomoda, Takeshi; Ueki, Toshiharu; Yamasaki, Tomoaki; Sakata, Yuhei; Katayama, Toshihiro; Kawamura, Takashi; Kawamoto, Hirofumi.
Afiliação
  • Nebiki H; Department of Gastroenterology, Osaka City General Hospital, 2-13-22 Miyakojimahondori, Miyakojima-Ku, Osaka, Japan. nebiki@nn.iij4u.or.jp.
  • Fujita K; Department of Gastroenterology and Hepatology, Yodogawa Christian Hospital, Osaka, Japan.
  • Yazumi S; Department of Gastroenterology and Hepatology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka, Japan.
  • Takenaka M; Department of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Osaka-Sayama, Japan.
  • Maruo T; Department of Gastroenterology, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
  • Matsumoto K; Division of Gastroenterology and Nephrology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Yonago, Japan.
  • Asada M; Department of Gastroenterology and Hepatology, Japanese Red Cross Osaka Hospital, Osaka, Japan.
  • Eguchi T; Department of Gastroenterology and Hepatology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan.
  • Matsubara T; Toyonaka Municipal Hospital, Toyonaka, Japan.
  • Yasumura S; Kobe City Medical Center West Hospital, Kobe, Japan.
  • Matsumoto H; Department of Gastroenterology and Hepatology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
  • Tamura T; Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.
  • Marui S; Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Hasegawa K; Takatsuki General Hospital, Takatsuki, Japan.
  • Mitoro A; Department of Gastroenterology, Nara Medical University, Kashihara, Japan.
  • Masuda A; Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Takada R; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Minami R; Department of Gastroenterology, Tenri Hospital, Nara, Tenri, Japan.
  • Ogura T; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Hoki N; Department of Gastroenterology, Bellland General Hospital, Sakai, Japan.
  • Funatsu E; Department of Gastroenterology, Chibune General Hospital, Osaka, Japan.
  • Kurita A; Department of Gastroenterology and Hepatology, Rakuwakai Otowa Hospital, Kyoto, Japan.
  • Onoyama T; Division of Gastroenterology and Nephrology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Yonago, Japan.
  • Tomoda T; Department of Gastroenterology, Okayama City Hospital, Okayama, Japan.
  • Ueki T; Department of Gastroenterology, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
  • Yamasaki T; Department of Gastroenterology, Osaka City General Hospital, 2-13-22 Miyakojimahondori, Miyakojima-Ku, Osaka, Japan.
  • Sakata Y; Department of Gastroenterology, Osaka City General Hospital, 2-13-22 Miyakojimahondori, Miyakojima-Ku, Osaka, Japan.
  • Katayama T; Faculty of Health Sciences Department of Medical Engineering, Morinomiya University of Medical Sciences, Osaka, Japan.
  • Kawamura T; Kyoto University Health Service, Kyoto, Japan.
  • Kawamoto H; Kawasaki Medical School, General Internal Medicine 2, General Medical Center, Kawasaki Medical School, Okayama, Japan.
Surg Endosc ; 37(5): 3463-3470, 2023 05.
Article em En | MEDLINE | ID: mdl-36575219
ABSTRACT

BACKGROUND:

There is no consensus on the necessity of endoscopic sphincterotomy (ES) to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) after endoscopic stenting in patients with malignant biliary obstruction. We investigated the incidence of PEP after endoscopic biliary stenting for malignant biliary obstruction with or without ES in a multicenter prospective cohort study.

METHODS:

We enrolled 807 patients who underwent endoscopic biliary stenting for malignant biliary obstruction with a native papilla at 36 hospitals between April 2017 and March 2018. The incidence of PEP in patients with or without ES was compared for subgroups based on stent type, placement method, and patient background. Univariate and multivariate analysis was performed to investigate the incidence of PEP in all stenting patients.

RESULTS:

Plastic and metal stents (MS) were inserted in 598 and 209 patients, respectively. The incidence of PEP in patients with or without ES was 7.9% and 7.4%, respectively among all stenting patients. The incidences of PEP with or without ES in plastic stent insertion patients, patients with MS insertion, stent insertions across the papilla, stent insertions across the papilla in patients without main pancreatic duct obstruction, and fully covered MS insertions across the papilla were compared. There was no overall significant difference in the incidence of PEP between those with or without ES. Multivariate logistic regression analysis for the incidence of PEP in all stenting patients revealed obstruction of the main pancreatic duct at the pancreatic head and epinephrine spraying on the papilla were significant factors; there was no significant difference in the incidence of PEP between patients with or without ES.

CONCLUSION:

Endoscopic sphincterotomy may not contribute to the prevention of PEP after endoscopic biliary stenting for malignant biliary obstruction, even in cases of insertion with a fully covered MS across the papilla.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pancreatite / Colestase Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pancreatite / Colestase Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article